Supercomputer simulation tackles problem of drug-resistant bacteria

A first-ever, atom-by-atom supercomputer simulation shows how antibiotics kill bacteria and illustrates other processes of the molecular machinery in living cells. The research opens fresh pathways to improving antibiotics, designing new ones to fight drug-resistant bacteria and developing vaccines for viruses such as SARS-CoV-2, which causes COVID-19.